Recurrent Pregnancy Loss
Experiencing pregnancy loss can be deeply distressing, particularly when it happens more than once. Understanding possible contributing factors is an important step toward finding answers and regaining a sense of control. Through careful assessment and personalised investigation, we can identify potential causes and create a plan tailored to your needs. I’m here to support you with compassionate, evidence-based care - helping you make sense of your experiences, explore your options, and move forward with clarity, reassurance, and hope for a healthy pregnancy.
“Understanding recurrent pregnancy loss helps you make sense of your experiences, explore your options, and feel supported and empowered on your journey toward a healthy pregnancy.”
Recurrent Pregnancy Loss (RPL)
Expert assessment, clear answers, and supportive care
Recurrent pregnancy loss (RPL) affects 1-2% of women and can be emotionally devastating. It’s definition has been an area of debate. ESHRE guidelines define it as two or more consecutive pregnancy losses. Many causes are identifiable and treatable with the right evaluation.
Comprehensive Evaluation for RPL
Genetic: Parental karyotype, products-of-conception testing when appropriate
Endocrine: Thyroid disorders, hyperprolactinaemia, PCOS, luteal phase deficiency
Anatomical: Uterine septum, adhesions, fibroids, polyps (3D ultrasound ± hysteroscopy)
Immunological/Haematological: Antiphospholipid syndrome (APS) testing, inherited thrombophilias (selective testing)
Lifestyle & metabolic factors: Weight, nutrition, smoking, alcohol, environmental exposures
Male factor: Semen analysis, sperm DNA fragmentation (if indicated)
Treatment Options
Progesterone supplementation (per PRISM and PROMISE data – benefit in early pregnancy bleeding and selected women)
Surgical correction of uterine septum, polyps, adhesions
Endocrine optimisation - thyroid, prolactin treatment, metabolic support
APS-specific therapy (low-dose aspirin ± heparin as per guideline)
Lifestyle optimisation and preconception planning
Chromosomally tested embryos (PGT-A) in selected cases where recurrent aneuploidy is suspected
Emotional and psychological support
RPL demands clinical expertise and sensitive care. Dr Rebecca Mackenzie-Proctor works closely with patients to understand the cause, explain findings clearly, and develop a plan that improves the likelihood of a healthy pregnancy while addressing the emotional impact.
Recurrent Implantation Failure (RIF)
Investigation and tailored strategies for those struggling to achieve implantation
Recurrent implantation failure is typically defined as failure to achieve a clinical pregnancy after transfer of multiple high-quality embryos, usually ≥3 blastocysts or embryo transfers depending on patient age and circumstances.
Assessment Framework
A comprehensive evaluation includes:
Embryo-related factors
Embryo morphology, blastocyst development, aneuploidy rates
Consideration of PGT-A
Culture review with embryology team
Uterine & endometrial factors
3D ultrasound, saline infusion sonogram or hysteroscopy
Endometrial thickness, pattern, polyps, adhesions
Chronic endometritis screening when appropriate
Hormonal & systemic factors
Thyroid function, prolactin, metabolic assessment
Luteal phase adequacy
Vitamin D and micronutrient profile
Transfer technique & laboratory factors
Review of transfer difficulty
Endometrial preparation protocol (natural, modified natural, HRT cycle)
Timing of progesterone exposure and receptivity window
Lifestyle & environmental factors
Weight, sleep, nutrition, exercise, endocrine disruptor exposure
Smoking, alcohol, stress management
Evidence-Based Treatment Options
Optimisation of transfer technique
Endometrial preparation individualised to natural cycles, modified natural, or HRT
Hysteroscopy to address adhesions or polyps
Treatment of chronic endometritis (if confirmed)
Progesterone protocol adjustment
Addressing metabolic, thyroid, and hormonal conditions
Considering PGT-A in selected cases
Lifestyle optimisation programs (nutrition, stress support, antioxidant strategies)
Note: Immune therapies such as intralipids or steroids are not recommended without an evidence-based indication.
RIF requires a precision-medicine approach. Dr Rebecca Mackenzie-Proctor collaborates with fertility scientists, embryologists, and multidisciplinary specialists to optimise every factor: embryo quality, endometrium, transfer technique, and systemic health. Care is transparent, data-driven, and aligned with international evidence.